tiprankstipranks
Trending News
More News >
4DMedical Ltd (AU:4DX)
ASX:4DX
Australian Market
Advertisement

4DMedical Ltd (4DX) Stock Statistics & Valuation Metrics

Compare
55 Followers

Total Valuation

4DMedical Ltd has a market cap or net worth of AU$358.51M. The enterprise value is AU$109.16M.
Market CapAU$358.51M
Enterprise ValueAU$109.16M

Share Statistics

4DMedical Ltd has 465,596,600 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding465,596,600
Owned by Insiders0.77%
Owned by Institutions

Financial Efficiency

4DMedical Ltd’s return on equity (ROE) is -0.51 and return on invested capital (ROIC) is -28.27%.
Return on Equity (ROE)-0.51
Return on Assets (ROA)-0.30
Return on Invested Capital (ROIC)-28.27%
Return on Capital Employed (ROCE)-0.28
Revenue Per Employee25.89K
Profits Per Employee-248.13K
Employee Count145
Asset Turnover0.03
Inventory Turnover0.24

Valuation Ratios

The current PE Ratio of 4DMedical Ltd is ―. 4DMedical Ltd’s PEG ratio is ―.
PE Ratio
PS Ratio
PB Ratio
Price to Fair Value2.51
Price to FCF
Price to Operating Cash Flow-15.73
PEG Ratio

Income Statement

In the last 12 months, 4DMedical Ltd had revenue of 3.75M and earned -35.98M in profits. Earnings per share was -0.11.
Revenue3.75M
Gross Profit3.52M
Operating Income-27.97M
Pretax Income-35.93M
Net Income-35.98M
EBITDA-31.86M
Earnings Per Share (EPS)-0.11

Cash Flow

In the last 12 months, operating cash flow was -30.28M and capital expenditures -96.03K, giving a free cash flow of -30.37M billion.
Operating Cash Flow-30.28M
Free Cash Flow-30.37M
Free Cash Flow per Share-0.07

Dividends & Yields

4DMedical Ltd pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta2.16
52-Week Price Change211.90%
50-Day Moving Average0.41
200-Day Moving Average0.40
Relative Strength Index (RSI)88.09
Average Volume (3m)4.55M

Important Dates

4DMedical Ltd upcoming earnings date is Mar 4, 2026, Before Open (Confirmed).
Last Earnings DateAug 28, 2025
Next Earnings DateMar 4, 2026
Ex-Dividend Date

Financial Position

4DMedical Ltd as a current ratio of 1.78, with Debt / Equity ratio of 8.05%
Current Ratio1.78
Quick Ratio1.74
Debt to Market Cap0.00
Net Debt to EBITDA0.80
Interest Coverage Ratio-105.95

Taxes

In the past 12 months, 4DMedical Ltd has paid 48.41K in taxes.
Income Tax48.41K
Effective Tax Rate>-0.01

Enterprise Valuation

4DMedical Ltd EV to EBITDA ratio is -4.80, with an EV/FCF ratio of -4.90.
EV to Sales40.69
EV to EBITDA-4.80
EV to Free Cash Flow-4.90
EV to Operating Cash Flow-4.95

Balance Sheet

4DMedical Ltd has AU$15.95M in cash and marketable securities with AU$4.82M in debt, giving a net cash position of -AU$11.13M billion.
Cash & Marketable SecuritiesAU$15.95M
Total DebtAU$4.82M
Net Cash-AU$11.13M
Net Cash Per Share-AU$0.02
Tangible Book Value Per Share>-AU$0.01

Margins

Gross margin is 93.60%, with operating margin of -744.92%, and net profit margin of -958.34%.
Gross Margin93.60%
Operating Margin-744.92%
Pretax Margin-957.05%
Net Profit Margin-958.34%
EBITDA Margin-848.55%
EBIT Margin-956.82%

Analyst Forecast

The average price target for 4DMedical Ltd is AU$0.77, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price TargetAU$0.77
Price Target Upside-41.22% Downside
Analyst ConsensusModerate Buy
Analyst Count3
Revenue Growth Forecast55.91%
EPS Growth Forecast-52.84%

Scores

Smart Score10
AI Score52
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis